Clinical Performance Summary - Defibrillation

Clinical Performance Summary - Defibrillation

An international, multicenter, prospective, randomized, clinical study was conducted to assess the effectiveness of the SMART Biphasic waveform in out-of-hospital sudden cardiac arrests (SCAs), as compared to monophasic waveforms. The primary objective of the study was to compare the percent of patients with ventricular fibrillation (VF) as the initial monitored rhythm that were defibrillated in the first series of three shocks or less.

This section summarizes the methods and results of this study.

Methods

Victims of out-of-hospital SCA were prospectively enrolled in four emer- gency medical service (EMS) systems. Responders used either 150J SMART Biphasic AEDs or 200-360J monophasic waveform AEDs. A sequence of up to three defibrillation shocks were delivered. For the biphasic AEDs, there was a single energy output of 150J for all shocks. For monophasic AEDs, the shock sequence was 200, 200, 360J. Defibrillation was defined as termination of VF for at least five seconds, without regard to hemodynamic factors.

Results

Randomization to the use of monophasic or SMART Biphasic automatic external defibrillators (AEDs) was done in 338 SCAs from four emergency medical service systems. VF was observed as the first monitored rhythm in 115 patients. The biphasic and monophasic groups for these 115 patients were similar in terms of age, sex, weight, primary structural heart disease, cause or location of arrest, and bystanders witnessing the arrest or performing CPR.

The 150J SMART Biphasic waveform defibrillated 98% of VF patients in the first series of three shocks or less, compared with 69% of patients treated with monophasic waveform shocks. Outcomes are summarized in Table 13-3.

13-14

Specifications & Safety

Page 160
Image 160
Philips M3500B manual Clinical Performance Summary Defibrillation, Methods, Results